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ABSTRACT
Context: The incidence of breast cancer is increasing worldwide. In black women, breast cancer is associated with aggressive 
features and poor survival.
Objective: Identification of risk factors such as early age of menarche, obesity and family history of breast cancer may 
permit preventive strategies.
Study Design: A cross‑sectional comparative study design was used and questionnaires were administered to 400 adult 
women at a tertiary health centre in Nigeria. The data was analyzed with the Statistical Package for the Social Sciences 
version 17; the level of significance set at alpha = 0.05.
Results: There was significant association between pre‑menopausal and post‑menopausal women with positive family 
history of breast cancer with P = 0.010. Majority of the respondents with a positive family history of breast cancer were 
menopausal (P = 0.010). There was a statistically significant association between menopausal status and ever consuming 
alcohol‑based herbal concoctions (P = 0.010) and in those whose partners smoked cigarettes (P = 0.001). Majority of 
respondents were not currently on any form of contraceptives. Parity, breastfeeding and use of hormonal contraceptives 
were all statistically significant (P < 0.001, P < 0.001 and P = 0.004, respectively). Almost all the women in our study, 97%, 
had never had a mammogram. There was a significant association between pre‑menopausal and post‑menopausal women 
with positive family history of breast cancer (P = 0.010).
Conclusion: With increasing incidence of breast cancer worldwide and late presentation in developing countries with high 
morbidity and mortality, effective screening for risk factors will go a long way in reducing the incidence of breast cancer.
Key words: Breast cancer; Nigeria; risk factors; women.
Introduction
Breast cancer is a non‑communicable disease of huge public 
health importance and is the most common cancer in 
women in Nigeria and worldwide.[1,2] Globally, the incidence 
of breast cancer is increasing and even more so in societies 
that previously had a low incidence of the disease.[3] The 
highest number of deaths from breast cancer are from the 
United Kingdom, where approximately 42000 new cases 
are diagnosed annually, with a mortality rate of 15000 per 
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annum.[4] In the United States of America, the incidence rate 
of breast cancer is 200,000 per annum, with a mortality of 
about 40000 per year.[4]
The prevalence of breast cancer in Nigeria was 116 per 
100,000 and 27840 new cases were expected to develop in 
1999.[2] In a more recent retrospective study by Agbo et al., 
reported in 2014 from the northern part of Nigeria, the 
prevalence rate of breast cancer was found to be 10.4 cases 
per 100,000.[5] The incidence rate of breast cancer in Nigeria 
has steadily increased from 15.3 per 100,000 in 1976 to 33.6 
per 100,000 in 1992.[6] Jedy‑Agba et al., in 2012, analyzed 
data from the Ibadan Population Based Cancer Registry (IBCR) 
and the Abuja Population Based Cancer Registry (ABCR) and 
reported an age standardized incidence rate (ASR) of breast 
cancer of 52.0 per 100,000 women in Ibadan, Nigeria and 
64.6 per 100,000 women in Abuja, Nigeria.[7] Akarolo‑Anthony 
et al., in 2010, reported that in Nigeria, there was a rise in the 
number of women at risk of breast cancer from approximately 
24.5 million in 1990 to approximately 40 million in 2010 and 
will likely reach over 50 million by 2020.[8] Reasons adduced 
for the high incidence of cancer now in Nigeria could be 
increased reporting and improved diagnosis.[4] There is also 
a trend toward westernization in developing countries, with 
the change in demographic profile and lifestyle, and the 
changing socioeconomic profile of the country.
In assessing the risk of developing breast cancer, a 
multidisciplinary team approach should be employed. 
Medical and surgical history, history of exposure to possible 
carcinogens and a detailed family history of cancer is obtained 
while physical examination and radiologic imaging studies 
are also done.[9] The factors to be elaborated upon for 
pre‑menopausal women include increasing age, the density 
of the breast, history of breast or ovarian cancer in any 
family member and previous procedures on the breast.[10] For 
post‑menopausal women, areas of emphasis are age, breast 
density, race, ethnicity (especially Ashkenazi Jewish), family 
history of breast cancer, a breast procedure in the past, body 
mass index, menopause occurring naturally, hormone therapy, 
and a previous false‑positive mammogram.[10]
Notable risk factors for breast cancer include age at menarche, 
first child birth, and menopause; parity; number of breast 
biopsies done in the past; histological findings of atypical 
hyperplasia or lobular carcinoma in situ in breast tissue; use 
of oral contraceptive pills and nulliparity.[9] There are also 
environmental influences important in the aetiology of breast 
cancer, as well as genetic factors.[3,11] Approximately 5–10% 
of breast cancers are familial and mutations in breast cancer 
susceptibility genes – BRCA 1 and BRCA 2 – are responsible 
for 80% of the familial cases while sporadic cases are rare.[1]
Other risk factors include previous thoracic radiation therapy 
and the use of hormones with history of present or past use 
of oestrogen and progesterone. Body mass index, breast 
density at mammography, alcohol consumption, diet and 
physical activity are also implicated.[9] In a case‑control study 
of the epidemiological risk factors for breast cancer done 
in the Oncology clinic of University College Hospital (UCH), 
Ibadan, the mean patient age of 43 years was obtained and it 
was also found that the incidence of breast cancer in Nigeria 
was increasing.[3]
The incidence of breast cancer increases with age and 
doubles every 10 years till menopause.[12] In the Western 
world, the age specific incidence of breast cancer appears 
to increase with age. Approximately 50% of breast cancers 
occur in the age group 50–65 years and 30% occur over 
the age of 70 years.[4] Breast cancers in Nigerian women is, 
however, noted to present a decade earlier than in developed 
countries.[4,13] The age at development of breast cancer is 
reducing with worse prognosis in black women, and in these 
group of women, breast cancer has aggressive features and 
poor survival.[6] The global age‑standardized mortality rate 
for female breast cancer is shown in Figure 1, with some of 
the highest mortality rates found in Africa. Determining a 
woman’s breast cancer risk will allow early detection and 
prompt treatment. Low technology, low‑cost management 
options and examining the value of genetic risk factors 
of breast cancer in determining a population at risk are 
required.[3]
The incidence of breast cancer is increasing rapidly in Nigeria, 
therefore, there is a need for determining the pattern of 
breast cancer risk factors among pre‑ and post‑menopausal 
women and encouraging appropriate follow‑up of clients 
with high risk of breast cancer.
Materials and Methods
This was a cross‑sectional comparative study and was 
conducted among 400 adult female patients above the age 
Figure 1: Estimated age-standardised mortality rates of female breast cancer 
by country. [GLOBOCAN 2008]. The numbers in brackets within the legend 
show how many countries are included in each mortality range
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of 18 years attending the General Outpatients (GOP) clinic of 
the Department of Family Medicine, UCH, Ibadan, Oyo State, 
Nigeria for the first time over a period of 7 months. Ibadan 
is the largest city in west Africa, and has a population of 2.9 
million people.[14] Women who were too ill to go through the 
rigours of the study and pregnant women were excluded.
The sample size was estimated by using the formula for 
simple proportions with an expected average prevalence 
of combined breast cancer risk of 33%.[15] The following 
assumptions were also made: Type 1 error was 0.05, the 
area under the normal curve was equivalent to 1.96 at 95% 
confidence interval and the precision was 5%.The consecutive 
sampling method was adopted in recruiting the participants. 
Validated questionnaires with sections on assessment of 
sociodemographic characteristics, gynaecological history, 
breast cancer screening, family history and lifestyle factors 
were administered by the interviewer after informed consent 
was obtained from the participants. The University of Chicago 
Cancer risk clinic new patient risk assessment questionnaire 
was adopted. Data were collected over a period of 7 months. 
Body mass index was used to define and classify obesity.[16]
Approval was obtained from the Head of Department of 
Family Medicine, UCH, Ibadan and the ethics committee of 
the joint University of Ibadan (UI)/UCH institutional review 
board. The UI/UCH EC registration number obtained was 
NHREC/05/01/2008a. All patients recruited were given health 
education and referred appropriately to general surgery 
and/or radiotherapy specialists within the health facility for 
further evaluation and management, if indicated.
The data collected from the participants were coded serially, 
cleaned and entered into a computer using the software 
programme; Statistical Package for Social Sciences for data 
analysis (SPSS® version 17) was used for data analysis. 
Discrete variables were summarized using proportions 
and Chi‑square test were used to explore statistical 
relationships.
Results
The frequency distribution of sociodemographic characteristics 
of the 400 respondents is shown in Table 1. Over two‑thirds of 
the women were pre‑menopausal with the highest proportion 
of women being between 25 and 34 years old. The greatest 
proportion of women who were post‑menopausal was those 
above 55 years of age. All the single respondents were 
pre‑menopausal. Majority of the married respondents were 
pre‑menopausal (69.5%), whereas many of the widowed 
respondents were post‑menopausal (79.5%).
Among the pre‑menopausal group of respondents, the 
highest level of education of the respondents was tertiary 
education (81.6%) followed by secondary education (79.6%). 
However, among the post‑menopausal group of respondents, 
non‑formal education (76.3%) was the most common 
followed by primary education (60.4%). Most of the 
pre‑menopausal respondents were students (94%), whereas 
majority of the post‑menopausal respondents were 
traders (38.3%). Many (71.4%) of the premenopausal women 
were Christians whereas the highest proportion among the 
post‑menopausal women were Muslims (33.3%). The Igbo 
tribe was the most predominant among the post‑menopausal 
respondents (33.3%), whereas it was the least among the 
pre‑menopausal group of respondents (66.7%).
The distribution of lifestyle and risks factors of the respondents 
is depicted in Table 2. Out of the 400 respondents in this 
study, 280 (70%) were pre‑menopausal whereas 120 (30%) 
were post‑menopausal. Only a small proportion 15 (3.8%) 
of the respondents had a positive family history of breast 
cancer with the majority 9 (60.0%) being post‑menopausal. 
Table 1: Frequency distribution of socio‑demographic 
characteristics of the respondents
Characteristics Pre‑menopausal 
n (%)
Post‑menopausal 
n (%)
Total 
N (%)
Age group (years)
≤24 38 (97.4) 1 (2.6) 39 (100.0)
25-34 101 (100.0) 0 (0.0) 101 (100.0)
35-44 94 (87.9) 13 (12.1) 107 (100.0)
45-54 43 (43.0) 57 (57.0) 100 (100.0)
55 above 4 (7.5) 49 (92.5) 53 (100.0)
Marital status
Single 75 (100.0) 0 (0.0) 75 (100.0)
Married 194 (69.5) 85 (30.5) 279 (100.0)
Separated/Divorced 3 (42.9) 4 (57.1) 7 (100.0)
Widowed 8 (20.5) 31 (79.5) 39 (100.0)
Level of education
Non-formal education 9 (23.7) 29 (76.3) 38 (100.0)
Primary 21 (39.6) 32 (60.4) 51 (100.0)
Secondary 82 (79.6) 21 (20.4) 103 (100.0)
Tertiary 168 (81.6) 38 (18.4) 206 (100.0)
Occupation
Trader 121 (61.7) 75 (38.3) 196 (100.0)
Civil servant 76 (74.5) 26 (25.5) 102 (100.0)
Student 47 (94.0) 3 (6.0) 50 (100.0)
Others 36 (69.2) 16 (30.8) 52 (100.0)
Religion
Christianity 200 (71.4) 80 (28.6) 280 (100.0)
Islam 80 (66.7) 40 (33.3) 120 (100.0)
Ethnic group
Yoruba 246 (70.3) 104 (29.7) 350 (100.0)
Igbo 22 (66.7) 11 (33.3) 33 (100.0)
Others 12  (70.6) 5  (29.4) 17 (100.0)
*Significant  at P<0.05
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There was significant association between pre‑menopausal 
and post‑menopausal women with positive family history of 
breast cancer with P = 0.010.
Only 2 (66.7%) of the pre‑menopausal women and 1 (33.3%) 
post‑menopausal women had ever undergone surgical 
procedures such as hysterectomy and oophorectomy. 
There was no significant association between pre and 
post‑menopausal women and ever having any surgical 
procedures (P = 0.899). Majority of the respondents, 
9 (69.2%) and 11 (68.8%), respectively, were currently 
consuming alcohol at least once a week and had ever 
consumed alcohol once a week for six months or longer 
were pre‑menopausal.
Twenty‑two (5.5%) of the respondents had taken 
alcohol‑based herbal concoction, out of which 12 (54.5%) 
of the respondents were post‑menopausal. There was a 
statistically significant association between ever consuming 
alcohol‑based herbal concoctions (P = 0.010). Only 
one (0.3%) of the respondents had ever chewed tobacco and 
was pre‑menopausal. Fourteen (3.5%) of the respondents 
had their spouses smoking cigarettes. There was a 
statistically significant association between pre‑menopausal 
and post‑menopausal women whose partners smoked 
cigarettes (P = 0.001).
The highest proportion 158 (40.1%) of the respondents 
were of normal weight. This was followed by overweight 
112 (28.4%) and obese respondents were 93 (23.6%) with 
class 1 being predominant 60 (64.5%). There was no 
statistically significant association between pre‑menopausal 
and post‑menopausal women who were obese using the body 
mass index category (P = 0.118).
The gynaecological history of the respondents is shown in 
Table 3. The mean age at menarche was 14.76 and 15.2 years 
for the pre‑menopausal and post‑menopausal group of 
women, respectively (standard deviation: ±2.3 years). 
Seventy‑seven (19.3%) women were nulliparous and 
mainly pre‑menopausal (96.1%). Approximately one‑third 
of the women in the study were parous [323 (80.8%)]. The 
majority 161 (55.1%) were in the para 2–4 category. The 
pre‑menopausal set constituted approximately 70% of women 
in the 2–4 parous categories. The post‑menopausal women 
contributed only 30%.
Most 285 (75.8%) out of 376 women in our study 
breastfed their children. Those in the pre‑menopausal 
category were predominant among those who breastfed 
or did not breastfeed 175 (61.4%) and 82 (90.1%), 
respectively (OR = 0.18: CI = 0.08–0.36). Majority of 
women 184 (66.9%) breastfed for more than 1 year with 
the pre‑menopausal fraction being the most predominant 
116 (68.6%). Most women 289 (72.3%) had never used 
any method of hormonal family planning. One hundred 
and eleven women (27.8%) out of 400 women evaluated 
had ever used a hormonal family planning method. Sixty 
percent (66) were pre‑menopausal whereas 41% (45) were 
post‑menopausal. The pre‑menopausal women 214 (74.0%) 
Table 2: Lifestyle and risk factors of the respondents
Characteristics Pre‑menopausal 
n (%)
Post‑menopausal 
n (%)
P
Has any family member 
ever been diagnosed 
with cancer?
Yes 6 (40.0) 9 (60.0) 0.010*
No 274 (71.2) 111 (28.8)
Ever had any surgical 
procedure (hysterectomy, 
oophorectomy)?
Yes 2 (66.7) 1 (33.3) 0.658
No 278 (70.0) 119 (53.4)
Ever consumed any 
alcohol once a week for 
6months?
Yes 11 (68.8) 5 (31.2) 0.911
No 269 (46.4) 115 (29.9)
Currently consuming 
alcohol at least once a 
week?
Yes 9 (69.2) 4 (30.8) 0.951
No 271 (70.0) 116 (30.0)
Do you take herbal 
concoction with alcohol 
base?
Yes 10 (45.5) 12 (54.5) 0.010*
No 270 (71.4) 108 (28.6)
Ever smoked at least 
1 cigarette daily for 3 
months?
Yes 0 (0.0) 2 (100.0) 0.089
No 280 (70.4) 118 (29.6)
Do you chew tobacco?
Yes 1 (100.0) 0 (0.0) 0.700
No 279 (69.9) 120 (30.1)
Does your partner 
smoke?
Yes 4 (28.6) 10 (71.4) 0.001*
No 276 (71.5) 110 (28.5)
Body mass index
Underweight 26 (83.9) 5 (16.1) 0.118
Normal weight 118 (74.7) 40 (25.3)
Overweight 72 (64.3) 40 (35.7)
Obesity class 1 39 (65.0) 21 (35.0)
Obesity class 2 15 (57.7) 11 (42.3)
Obesity  class  3 5  (71.4) 2  (28.6)
*Significant  at P<0.05
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predominated in this set. Intrauterine contraceptive device 
(IUCD), injectables and oral contraceptives were the three 
most  frequently used forms of hormonal contraceptive 
by pre‑menopausal women, i.e. 24 (47.1%), 21 (77.8%), 10 
(76.9%), respectively;  whereas, IUCD was the single most 
common form of hormonal contraceptive used by post‑
menopausal women. Majority of women in our study were 
not on any form of contraceptive. Parity, breastfeeding 
and use of hormonal contraceptives were statistically 
significant (P < 0.001, P < 0.001 and P = 0.004, 
respectively), however, the duration of breastfeeding was 
not statistically significant.
Most women in our study 97% never had a mammogram and 
two‑thirds 273 were pre‑menopausal (70.4%). Two‑hundred 
and thirty‑three women (58.3%) had examined their own 
breasts for lumps whereas 167 (41.8%) did not examine 
their breasts. In both groups, the pre‑menopausal fraction 
constituted approximately two‑third of the women (70.4% 
and 69.5%, respectively).
The proportion of women who examined their breasts for 
lumps and those who did not examine their breast were 58.3% 
and 41.8%, respectively. The proportion of women in both 
groups were alike 70.4% and 69.5% in the pre‑menopausal 
category and 29.6% and 30.5% in the post‑menopausal 
category, respectively.
The majority of women in our study 88.5% (354) had never 
detected a breast lump. Most of the women in this group were 
also pre‑menopausal, 69.5% (246), with only 30.5% (106) in 
the post‑menopausal group. Approximately 12% (46) of the 
400 women evaluated had detected a lump. In this category, 
the pre‑menopausal women also predominated 73.9% (34).
Mammography, breast examination and lump detection were 
not statistically significant (P = 0.371, P = 0.842 and 
P = 0.538, respectively).
Discussion
The highest proportion of women (26.8%) in this study 
were those between age 25–34 years for pre‑menopausal 
respondents and greater than 55 years for the post‑menopausal 
respondents. This is comparable to a study in Nigeria in which 
the women were found to be in a similar age group bracket.[17] 
In another Nigerian study, the highest prevalence of breast 
cancer was in those whose age group was 26 to 45 years,[18] 
whereas majority of cases in another study were in the age 
group 40 to 49 years.[19]
Most of the married women in the study were pre‑menopausal, 
whereas many of the widowed women were post‑menopausal. 
This was comparable to a study in southwestern Nigeria.[2] The 
highest level of education of the pre‑menopausal respondents 
in this study was tertiary education, whereas in the 
post‑menopausal women it was non‑formal education. This 
was in line with the study by Meshram et al. in 2009.[19]
Studies have linked the risk of developing breast cancer with 
positive family history in first degree relatives (FDR).[20] This 
finding was in agreement with our study, which revealed 
Table 3: Gynaecological history of the respondents
Characteristics Menopausal status 
(Pre) n (%)
Menopausal status 
(Post) n (%)
P
Age at First Menstrual 
Period
14.76±2.3 years 15.5±2.3 years
Parity
None
One 37 (86.0) 6 (14.0) 0.000*
2-4 112 (69.6) 49 (30.4)
>5 29 (33.0) 59 (67.0)
Did you breast feed
Yes 175 (61.4) 110 (38.6) 0.000*
No 82 (90.1) 9 (9.9)
Duration of breast 
feeding
0-6 months 8 (53.3) 7 (46.7) 0.679
7-12months 45 (59.2) 31 (40.8)
More than 1 year 116 (63.0) 68 (37.0)
Ever used any method 
of Hormonal family 
planning
Yes 66 (59.5) 45 (40.5) 0.004*
No 214 (74.0) 75 (26.0)
Type of hormonal 
family planning used
Oral contraceptives 10 (76.9) 3 (23.1) 0.030
Injectable 
hormonals
21 (77.8) 6 (22.2)
Hormonal implants 4 (50.0) 4 (50.0)
Intra Uterine device 24 (47.1) 27 (52.9)
Currently using any 
family planning
Yes 21 (70.0) 9 (30.0) 0.997
No 243 (70.0) 104 (30.0)
Ever Had 
Mammogram
Yes 7 (58.3) 5 (41.7) 0.371
No 273 (70.4) 115 (29.6)
Do you examine your 
breast for lumps
Yes 164 (70.4) 69 (29.6) 0.842
No 116 (69.5) 51 (30.5)
Have you ever 
detected a lump
Yes 34 (73.9) 12 (26.1) 0.538
No 246  (69.5) 108  (30.5)
*Significant  at P<0.05
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family history as a strong risk factor to developing breast 
cancer (P = 0.01). Cancer in FDR was considered more 
important in post‑menopausal women.[21]
Ovarian cancer risk is lowered more than 90% in women with 
BRCA1 or BRCA2 mutations who decided to have risk‑reducing 
salpingo‑oophorectomy. In this same population, prophylactic 
removal of the ovaries was found to be associated with 
approximately 50% reduction in the risk of breast cancer.[22] 
Our study, however, did not show any relationship between 
breast cancer and salpingo‑oophorectomy or hysterectomy.
The risk of breast cancer is said to increase by approximately 
10% for each 10 g of daily alcohol consumption.[23] Prior 
studies of BRCA1/BRCA2 mutation carriers, however, did not 
find any increased risk with alcohol intake.[24,25] Our study 
found no significant interaction between alcohol, duration 
of consumption and the period of onset of breast cancer in 
either pre‑menopausal or post‑menopausal women. This 
was also buttressed by the Tecumseh Community Health 
Study (TCHS).[26] There was, however, a strong association 
between consumption of alcohol‑based native medication 
and risk of developing breast cancer noted in our study, 
with (P = 0.01).
Weight gain and being overweight are well‑known risk 
factors for breast cancer. In general, overweight women 
are most commonly observed to be at a greater risk 
of post‑menopausal breast cancer and at lower risk of 
pre‑menopausal breast cancer. Sedentary lifestyle may also 
be a risk factor.[27] In our study, there was no statistically 
significant association between obesity using body mass 
index and being pre and post‑menopausal. One study[28] found 
a reduced risk of breast cancer among BRCA1/BRCA2 mutation 
carriers who smoked, however, an expanded follow‑up study 
failed to find an association.[29] Our study however revealed 
strong association between women whose spouses smoked 
cigarettes (P = 0.001).
In the woman’s contraceptive and Reproductive Experiences 
Study, women who reported having at least one full‑term 
pregnancy before the age of 25 years were at 36% reduced 
risk of breast cancer compared to nulligravida. Parous women 
in the study with a late age at first birth had an increased 
risk of both ERPR‑positive and ERPR‑negative tumors with 
each additional birth although neither result was statistically 
significant.[30] Low parity and late age at first birth were 
confirmed as significant and independent determinants of 
breast‑cancer risk.[31] Nulliparity was also associated with a 30% 
increase in risk compared with parous women, and for every 
two births, the risk was reduced by approximately 16%.[31]
A woman’s risk of developing breast cancer has been shown 
in various studies to be related to her exposure to hormones 
produced by her ovaries. Reproductive factors that increase 
the duration and/or levels of exposure to ovarian hormones, 
which stimulate cell growth, have been associated with an 
increase in breast cancer risk. These factors include early 
onset of menses, late onset of menopause, later age at first 
pregnancy and nulliparity. Pregnancy and breastfeeding 
are considered as protective against breast cancer as both 
reduce a woman’s lifetime number of menstrual cycles, 
and therefore her cumulative exposure to endogenous 
hormones.[32] In addition, pregnancy and breastfeeding have 
direct effects on breast cells, causing them to differentiate, 
or mature, so that they can produce milk. Some researchers 
hypothesize that these differentiated cells are more resistant 
to becoming transformed into cancer cells than cells that 
have not undergone differentiation.[33,34] Breastfeeding for 
an extended period (at least 1 year) is associated with 
a decreased risk of both hormone receptor‑positive and 
hormone receptor‑negative breast cancer.[35,36] International 
Agency for Research on Cancer (IARC) has classified the 
current or recent use of combined oestrogen‑progestogen 
oral contraceptives (OCs) as a cause of breast cancer.[37] OCs 
contain synthetic sex hormones, which may explain the 
link between OC use and breast cancer risk. An estimated 
1% of female breast cancers in the UK are linked to OCs 
because breast cancer risk is generally low in the OC‑using 
population (typically younger women).[38] A meta‑analysis 
showed that current users of OCs have approximately 24% 
higher breast cancer risk compared to never users and that 
breast cancers in OC users tend to be less advanced compared 
with those in OC never‑users.[39] The relative risk of breast 
cancer declines after OC cessation such that 10 years after 
cessation no excess risk remains.[39,40] Breast cancer risk does 
not appear to increase with longer duration of OC use. Young 
age at first OC use is associated with a larger increase in 
breast cancer risk.[39] The risks associated with OC use appears 
to be similar across OC formulations.[39,40]
Some types of benign breast disease are linked with increased 
breast cancer risk. Among women with benign breast disease, 
cancer is more common in the breast with the benign disease 
than in the opposite breast.[41] Breast cancer risk is generally 
not increased in women in non‑proliferative disease (NP). 
Proliferative disease without atypia (PDWA) has a breast 
cancer risk of 44% higher in women compared with women 
with NP.[42] However, breast cancer risk does appear to be 
increased in women with NP or PDWA and a FDR with breast 
cancer.[42] Atypical hyperplasia (AH) has close to a threefold 
higher risk for breast cancer in women compared with women 
with NP. Lobular AH is associated with higher breast cancer 
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risk than is ductal AH. Having a FDR with breast cancer does 
not appear to further increase breast cancer risk in women 
with AH.[42]
Breast cancer is a significant problem among women 
worldwide with associated high morbidity and mortality. The 
incidence of breast cancer is increasing worldwide with late 
presentation most especially in developing countries. Effective 
screening will go a long way in reducing the incidence of 
breast cancer. Effective screening through detailed family and 
gynaecological history with regular breast examination and 
radiological screening (sonomammogram and conventional 
mammogram) will allow for early diagnosis and prompt 
treatment of breast cancer, hence reducing morbidity and 
mortality associated with breast cancer. Mammograms should 
be encouraged as it has been reported in a Nigerian study 
that the level of awareness of mammograms is very low in 
Nigeria.[43] There was strong association between breast 
cancer and family history of breast and ovarian cancer among 
women attending the primary care clinic. This underscores 
the need for provision of screening services at the clinic and 
effective health education to promote preventive practices 
and inculcate a screening culture among women.
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